Filing Details
- Accession Number:
- 0001651308-20-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-05 16:46:51
- Reporting Period:
- 2020-05-01
- Accepted Time:
- 2020-05-05 16:46:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 981209416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739452 | Xiaobin Wu | C/O Mourant Governance Services (Cayman) 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108 | President & Gm China | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Disposition | 2020-05-01 | 5,255 | $140.96 | 1,769 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2020-05-01 | 1,224 | $142.54 | 545 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2020-05-01 | 300 | $143.17 | 245 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2020-05-01 | 245 | $141.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 1,416,815 | Direct | |
| American Depositary Shares | 15,365 | Direct | |
| American Depositary Shares | 4,000 | Indirect | By Wife |
Footnotes
- Includes 2,171 ordinary shares acquired pursuant to the Company's Second Amended and Restated Employee Share Purchase Plan.
- Each American Depositary Share represents 13 Ordinary Shares.
- Represents 15,365 American Depositary Shares previously reported in the Form 4 dated May 2, 2019, which were inadvertently omitted from subsequent reports.
- The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $143.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Billionaire Hedge Funds
